| 1 | Nature Biotechnology | 66.4 | 99th | Q1 | SCIE | – | No |
| 2 | Molecular Cancer | 55 | 99th | Q1 | SCIE | – | Yes |
| 3 | Cell Stem Cell | 36.1 | 98th | Q1 | SCIE | – | No |
| 4 | Clinical and Translational Medicine | 33.8 | 98th | Q1 | SCIE | – | Yes |
| 5 | Medicinal Research Reviews | 29.1 | 97th | Q1 | SCIE | – | No |
| 6 | Pharmacological Reviews | 25.9 | 96th | Q1 | SCIE | – | No |
| 7 | Trends in Molecular Medicine | 24 | 96th | Q1 | SCIE | – | No |
| 8 | Experimental and Molecular Medicine | 22.6 | 95th | Q1 | SCIE | – | Yes |
| 9 | Molecular Aspects of Medicine | 21.6 | 95th | Q1 | SCIE | – | No |
| 10 | Journal of Nanobiotechnology | 20.2 | 94th | Q1 | SCIE | – | Yes |
| 11 | Biomarker Research | 18.5 | 94th | Q1 | SCIE | – | Yes |
| 12 | Genome Medicine | 18 | 93th | Q1 | SCIE | – | Yes |
| 13 | Molecular Therapy | 17.9 | 93th | Q1 | SCIE | – | No |
| 14 | Journal for ImmunoTherapy of Cancer | 16.6 | 92th | Q1 | SCIE | – | Yes |
| 15 | Archives of Pharmacal Research | 13.6 | 91th | Q1 | SCIE | – | No |
| 16 | Cell Chemical Biology | 13.6 | 91th | Q1 | SCIE | – | No |
| 17 | Phytomedicine | 13.2 | 90th | Q1 | SCIE | – | No |
| 18 | EMBO Molecular Medicine | 13.1 | 90th | Q1 | SCIE | – | Yes |
| 19 | Pharmaceutical Biology | 12.4 | 89th | Q1 | SCIE | – | Yes |
| 20 | Cellular and Molecular Life Sciences | 12 | 89th | Q1 | SCIE | – | Yes |
| 21 | Stem Cell Research and Therapy | 11.9 | 88th | Q1 | SCIE | – | Yes |
| 22 | Molecular Biomedicine | 11.7 | 87th | Q1 | ESCI | – | Yes |
| 23 | Nucleic Acid Therapeutics | 11.4 | 87th | Q1 | SCIE | – | No |
| 24 | Acta Materia Medica | 11.4 | 86th | Q1 | – | – | Yes |
| 25 | Cancer Gene Therapy | 11.1 | 86th | Q1 | SCIE | – | No |
| 26 | Journal of Medicinal Chemistry | 11.1 | 85th | Q1 | SCIE | – | No |
| 27 | Molecular Therapy Nucleic Acids | 10.8 | 85th | Q1 | SCIE | – | Yes |
| 28 | BioFactors | 10.8 | 84th | Q1 | SCIE | – | No |
| 29 | Molecules | 10.3 | 84th | Q1 | SCIE | – | Yes |
| 30 | Nanomedicine: Nanotechnology, Biology, and Medicine | 10.3 | 83th | Q1 | SCIE | – | No |
| 31 | Gene Therapy | 10.1 | 82th | Q1 | SCIE | – | No |
| 32 | Probiotics and Antimicrobial Proteins | 10.1 | 82th | Q1 | SCIE | – | No |
| 33 | Molecular Diagnosis and Therapy | 10 | 81th | Q1 | SCIE | – | No |
| 34 | Expert Reviews in Molecular Medicine | 9.9 | 81th | Q1 | SCIE | – | Yes |
| 35 | Expert Review of Vaccines | 9.9 | 80th | Q1 | SCIE | – | Yes |
| 36 | Molecular Medicine | 9.7 | 80th | Q1 | SCIE | – | Yes |
| 37 | Molecular Therapy Oncology | 9.6 | 79th | Q1 | SCIE | – | Yes |
| 38 | Molecular Oncology | 9.4 | 79th | Q1 | SCIE | – | Yes |
| 39 | Pharmaceuticals | 9 | 78th | Q1 | SCIE | – | Yes |
| 40 | Biotechnology and Applied Biochemistry | 8.9 | 77th | Q1 | SCIE | – | No |
| 41 | Mitochondrion | 8.9 | 77th | Q1 | SCIE | – | No |
| 42 | Pharmaceutical Research | 8.7 | 76th | Q1 | SCIE | – | No |
| 43 | Cellular Oncology | 8.6 | 76th | Q1 | SCIE | – | Yes |
| 44 | Expert Opinion on Therapeutic Targets | 8.6 | 75th | Q1 | SCIE | – | No |
| 45 | Journal of Molecular Medicine | 8.6 | 75th | Q1 | SCIE | – | No |
| 46 | EXCLI Journal | 8.6 | 74th | Q2 | SCIE | – | Yes |
| 47 | European Journal of Medicinal Chemistry Reports | 8.5 | 74th | Q2 | ESCI | – | Yes |
| 48 | Cancer Biology and Therapy | 8.4 | 73th | Q2 | SCIE | – | Yes |
| 49 | Nature Mental Health | 8.1 | 72th | Q2 | ESCI | – | No |
| 50 | Transplantation and Cellular Therapy | 8.1 | 72th | Q2 | SCIE | – | No |
| 51 | Current Molecular Pharmacology | 7.8 | 71th | Q2 | SCIE | – | No |
| 52 | Molecular Therapy Methods and Clinical Development | 7.7 | 71th | Q2 | – | – | Yes |
| 53 | Molecular Pharmaceutics | 7.6 | 70th | Q2 | SCIE | – | No |
| 54 | Human Gene Therapy | 7.4 | 70th | Q2 | SCIE | – | No |
| 55 | Open Medicinal Chemistry Journal | 7.3 | 69th | Q2 | – | – | No |
| 56 | Molecular Medicine Reports | 7.3 | 68th | Q2 | SCIE | – | No |
| 57 | Virologica Sinica | 7.3 | 68th | Q2 | SCIE | – | No |
| 58 | Stem Cells | 7.3 | 67th | Q2 | SCIE | – | No |
| 59 | Biochimica et Biophysica Acta - Molecular Basis of Disease | 7.1 | 67th | Q2 | SCIE | – | No |
| 60 | Journal of Cellular and Molecular Medicine | 6.9 | 66th | Q2 | SCIE | – | Yes |
| 61 | ACS Chemical Biology | 6.9 | 65th | Q2 | SCIE | – | No |
| 62 | Frontiers in Genetics | 6.9 | 65th | Q2 | SCIE | – | Yes |
| 63 | Biointerface Research in Applied Chemistry | 6.8 | 65th | Q2 | – | – | No |
| 64 | Expert Review of Molecular Diagnostics | 6.8 | 64th | Q2 | SCIE | – | No |
| 65 | Molecular Informatics | 6.8 | 63th | Q2 | SCIE | – | No |
| 66 | Journal of Trace Elements in Medicine and Biology | 6.7 | 63th | Q2 | SCIE | – | No |
| 67 | Anti-Cancer Agents in Medicinal Chemistry | 6.7 | 62th | Q2 | SCIE | – | No |
| 68 | Profiles of Drug Substances, Excipients and Related Methodology | 6.7 | 62th | Q2 | – | – | No |
| 69 | Current Gene Therapy | 6.7 | 61th | Q2 | SCIE | – | No |
| 70 | Vascular Pharmacology | 6.5 | 61th | Q2 | SCIE | – | No |
| 71 | Current Medicinal Chemistry | 6.5 | 60th | Q2 | SCIE | – | No |
| 72 | Vaccine | 6.4 | 60th | Q2 | SCIE | – | No |
| 73 | Biomolecules and Therapeutics | 6.4 | 59th | Q2 | SCIE | – | No |
| 74 | Human Genomics | 6.4 | 58th | Q2 | SCIE | – | Yes |
| 75 | Journal of Natural Products | 6.3 | 58th | Q2 | SCIE | – | No |
| 76 | Journal of Molecular Diagnostics | 6.3 | 57th | Q2 | SCIE | – | No |
| 77 | Progress in Medicinal Chemistry | 6.3 | 57th | Q2 | – | – | No |
| 78 | Biomimetics | 6.2 | 56th | Q2 | SCIE | – | Yes |
| 79 | Human Genetics and Genomics Advances | 6.1 | 56th | Q2 | ESCI | – | Yes |
| 80 | Chemical Biology and Drug Design | 6.1 | 55th | Q2 | SCIE | – | No |
| 81 | Current Drug Targets | 6 | 55th | Q2 | SCIE | – | No |
| 82 | NeuroMolecular Medicine | 6 | 54th | Q2 | SCIE | – | No |
| 83 | Clinical Proteomics | 6 | 53th | Q2 | SCIE | – | Yes |
| 84 | Bioinspiration and Biomimetics | 5.9 | 53th | Q2 | SCIE | – | No |
| 85 | Analytical Cellular Pathology | 5.8 | 52th | Q2 | SCIE | – | Yes |
| 86 | Nucleus (India) | 5.8 | 52th | Q2 | ESCI | – | No |
| 87 | Biotechnology Journal | 5.7 | 51th | Q2 | SCIE | – | No |
| 88 | ChemMedChem | 5.7 | 51th | Q2 | SCIE | – | No |
| 89 | Pharmacogenomics Journal | 5.7 | 50th | Q2 | SCIE | – | No |
| 90 | RSC Medicinal Chemistry | 5.7 | 50th | Q2 | SCIE | – | No |
| 91 | Journal of Pharmacological Sciences | 5.7 | 49th | Q3 | SCIE | – | Yes |
| 92 | Bioorganic and Medicinal Chemistry | 5.6 | 48th | Q3 | SCIE | – | No |
| 93 | Function | 5.3 | 48th | Q3 | ESCI | – | Yes |
| 94 | Advances in Biological Regulation | 5.3 | 47th | Q3 | ESCI | – | No |
| 95 | Journal of Cardiovascular Translational Research | 5.3 | 47th | Q3 | SCIE | – | No |
| 96 | International Journal of Peptide Research and Therapeutics | 5.3 | 46th | Q3 | SCIE | – | No |
| 97 | Journal of Pharmacology and Experimental Therapeutics | 5.2 | 46th | Q3 | SCIE | – | No |
| 98 | Journal of Biochemical and Molecular Toxicology | 5.2 | 45th | Q3 | SCIE | – | No |
| 99 | Molecular Pharmacology | 5.2 | 44th | Q3 | SCIE | – | No |
| 100 | Phytochemical Analysis | 5.2 | 44th | Q3 | SCIE | – | No |